P

Prostatype Genomics AB
STO:PROGEN

Watchlist Manager
Prostatype Genomics AB
STO:PROGEN
Watchlist
Price: 9.25 SEK -4.64% Market Closed
Market Cap: 47.6m SEK
Have any thoughts about
Prostatype Genomics AB?
Write Note

Prostatype Genomics AB
PP&E Net

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Prostatype Genomics AB
PP&E Net Peer Comparison

Comparables:
BIOG B
BONEX
VITR
SOBI
BIOA B

Competitive PP&E Net Analysis
Latest Figures & CAGR of Competitors

Company PP&E Net CAGR 3Y CAGR 5Y CAGR 10Y
P
Prostatype Genomics AB
STO:PROGEN
PP&E Net
kr60k
CAGR 3-Years
26%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Biogaia AB
STO:BIOG B
PP&E Net
kr213.3m
CAGR 3-Years
9%
CAGR 5-Years
15%
CAGR 10-Years
N/A
Bonesupport Holding AB
STO:BONEX
PP&E Net
kr20.6m
CAGR 3-Years
11%
CAGR 5-Years
6%
CAGR 10-Years
N/A
Vitrolife AB
STO:VITR
PP&E Net
kr391m
CAGR 3-Years
35%
CAGR 5-Years
17%
CAGR 10-Years
16%
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
PP&E Net
kr384m
CAGR 3-Years
-7%
CAGR 5-Years
-5%
CAGR 10-Years
13%
BioArctic AB
STO:BIOA B
PP&E Net
kr31.1m
CAGR 3-Years
-8%
CAGR 5-Years
27%
CAGR 10-Years
N/A

See Also

What is Prostatype Genomics AB's PP&E Net?
PP&E Net
60k SEK

Based on the financial report for Dec 31, 2023, Prostatype Genomics AB's PP&E Net amounts to 60k SEK.

What is Prostatype Genomics AB's PP&E Net growth rate?
PP&E Net CAGR 3Y
26%

Over the last year, the PP&E Net growth was 1 567%. The average annual PP&E Net growth rates for Prostatype Genomics AB have been 26% over the past three years .

Back to Top